In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Latest From BASF SE

IPA's Jain On The Journey So Far And Fires To Douse

Sudarshan Jain, the new secretary general of the Indian Pharmaceutical Alliance and ex-Abbott managing director, wears many hats, including that of a senior advisor with a private equity advisory firm. He recounts having “survived in different cultures” in his career and outlines the priorities in his new role, amid continuing questions around generic quality.

India Commercial

Industry, NGOs Still Divided On Alternative Testing With EU Ingredient Innovation Stalled

Animal groups continue to call for a global ban on cosmetic animal testing while Cosmetics Europe advises outside jurisdictions to be prudent about prohibitions, noting that ingredient innovation has grinded to a halt in the EU in recent years. There does seem to be growing agreement between the camps that alternative methods are making important progress and show great promise compared with traditional standards.

Cosmetic Ingredients Regulation

Cosmetics News In Brief: ECHA Makes Non-Confidential REACH Data More Accessible

Stakeholders can now download a database of key study results for nearly 15,000 chemicals registered under the EU’s REACH regulation, benefiting from streamlined access to information that previously was more of a chore to compile, the European Chemicals Agency says. More news in brief.

Regulation Advertising, Marketing & Sales

Sunscreen Innovation Act Starts Clock Ticking On FDA Review Of TEAs

Congress passes legislation to provide an alternative process for reviewing UV filters to be added to the OTC drug sunscreen monograph. The bill’s passing during Congress’ lame duck session reflects not only bipartisan support, but also lobbying by the personal care product industry and consumer health advocates to impose deadlines on FDA for long-sought changes to the sunscreen monograph.

Consumer United States
See All

Company Information

  • Industry
  • Diversified
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Company Type
  • Midsize European
  • Parent & Subsidiaries
  • Senior Management
  • Jurgen Hambrecht, Chmn. & CEO
    Kurt Bock, CFO
  • Contact Info
    Phone: (49) 0621 600
    Carl-Bosch-Strasse 38
    Ludwigshafen, 67056